The Cardiovascular Biology and Metabolic Diseases program trains students to conduct research on the genetics and pathophysiology of diabetes, obesity, fatty liver disease, infertility and cardiovascular diseases, such as hypertension and atherosclerosis. The track emphasizes the use of genetically engineered rodents as a first step toward translating basic science research to the clinic. By fostering research on these diseases, which constitute the major causes of death in the US, this track prepares its graduates for active and independent research careers.
Of Special Interest:
The Cardiovascular Biology and Metabolic Diseases Ph.D. and M.S. programs are research-intensive and will combine rigorous coursework with sufficient time for intensive research activity. Previous students on average have completed the Ph.D. in five years or less and the M.S. in about 3 years. Graduates progress to post-doctoral training (Ph.D. degree) or to research, teaching, and other positions in academia, industry, and the government (Ph.D. and M.S. degrees).
Curriculum
Incoming graduate students will matriculate in the program with the track being undeclared. During the first year, students will take core courses and carry out laboratory rotations. Track-specific courses and laboratory rotations will be taken once the track of interest is identified. Students must pick the track and the laboratory to conduct their dissertation research project by the end of the first year. This infrastructure will promote rigorous and fruitful cross-fertilization between course work and laboratory research to prepare students for successful careers in academia, industry, and government agencies.
Admissions
Applications are processed on the Health Science Campus. For detailed admissions requirements and deadlines please contact the department.
